Emicizumab-kxwh Subcutaneous and M-End DMX
Determining the interaction of Emicizumab-kxwh Subcutaneous and M-End DMX and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: dexbrompheniramine / dextromethorphan / pseudoephedrine
Brand name: M-End DMX
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-M-End Max D
- Emicizumab-kxwh Subcutaneous-M-End PE
- Emicizumab-kxwh Subcutaneous-M-End WC
- Emicizumab-kxwh Subcutaneous-M-Hist DM
- Emicizumab-kxwh Subcutaneous-M-Hist PD
- Emicizumab-kxwh Subcutaneous-M-M-R II
- M-End DMX-Emla
- M-End DMX-Emla Topical
- M-End DMX-Emo-Cort Scalp Solution Topical application
- M-End DMX-Emo-Cort Topical application
- M-End DMX-Emoquette
- M-End DMX-Empagliflozin